The Claim

In rhesus monkeys undergoing hyperglycemic clamp and oral glucose tolerance tests, administration of E2HSA enhanced glucose-stimulated insulin secretion and reduced serum glucose fluctuations, indicating improved insulin response function during metabolic stress.

Source: A novel exendin-4 human serum albumin fusion protein, E2HSA, with an extended half-life and good glucoregulatory effect in healthy rhesus monkeys.

What the research says

Roughly balanced

Support and challenge are close. The picture may shift as more studies come in.

Supports
6score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In monkeys, a substance called E2HSA helped their bodies release more insulin when blood sugar went up and kept sugar levels more stable during tough metabolic tests.

See the scientific wording

During hyperglycemic clamp and oral glucose tolerance tests in rhesus monkeys, E2HSA improved glucose-stimulated insulin secretion and controlled serum glucose excursions, demonstrating functional enhancement of insulin response under metabolic challenge.

What the research says

1 study

  1. Study: A novel exendin-4 human serum albumin fusion protein, E2HSA, with an extended half-life and good glucoregulatory effect in healthy rhesus monkeys.

    The study tested E2HSA in monkeys and found it helped their bodies release more insulin and control blood sugar better when challenged with glucose, just like the claim says.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.